A groundbreaking advancement in the diagnosis of Parkinson's disease has been achieved through a skin biopsy technique that can detect an abnormal protein, phosphorylated α-synuclein, which is present in individuals with Parkinson’s and related disorders. This method, offering a 'window into the brain,' has shown a high proportion of accuracy in diagnosing not only Parkinson’s disease but also dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The detection of this protein in the skin could revolutionize the early diagnosis and treatment of these neurodegenerative diseases.
“Parkinson’s Disease Can Now Be Detected Through the Skin” Article: https://t.co/lI8dawHdMe
A more realistic artificial skin may lead to medical advances https://t.co/m7B1LVYMao
Could a skin biopsy diagnose Parkinson disease? Watch this video to learn more then read the JAMA study, “Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.” https://t.co/rJQauOplDp https://t.co/hwtr4AlBMe
In this study, a high proportion of individuals meeting clinical consensus criteria for Parkinson disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure had phosphorylated α-synuclein detected by skin biopsy. https://t.co/UYSW0LvDkE https://t.co/RtynHSgeE1
Parkinson’s disease can now be diagnosed with a skin biopsy that can detect an abnormal protein people with Parkinson’s have inside their nerves. “The skin test basically is a window into the brain." https://t.co/4Cf3TZwfVO https://t.co/4Cf3TZwfVO